Literature DB >> 960063

Intravenous arachidonate in the mouse: a model for the evaluation of antithrombotic drugs.

C Kohler, W Wooding, L Ellenbogen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 960063     DOI： 10.1016/0049-3848(76)90150-x

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  Inhibition of arachidonic acid induced mortality in rabbits with several non-steroidal anti-inflammatory agents.

Authors:  G DiPasquale; D Mellace
Journal:  Agents Actions       Date:  1977-10

2.  Anti-aggregatory effect of prostacyclin (PGI2) in vivo.

Authors:  B L Bayer; K E Blass; W Förster
Journal:  Br J Pharmacol       Date:  1979-05       Impact factor: 8.739

3.  Glucocorticoid protection against PAF-acether toxicity in mice.

Authors:  A Myers; E Ramey; P Ramwell
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

4.  Effects of 6-[p-(4-phenylacetylpiperazin-1-yl)phenyl]-4,5-dihydro-3(2H)pyridazinone (CCI 17810) and aspirin on platelet aggregation and adhesiveness.

Authors:  E M Griffett; S M Kinnon; A Kumar; D Lecker; G M Smith; E G Tomich
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

5.  Impaired metabolism of arachidonate in selenium deficient animals.

Authors:  T Masukawa; J Goto; H Iwata
Journal:  Experientia       Date:  1983-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.